Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey

References

• Bisno AL, Rijn IV. Classification of streptococci. Mandell, Douglas, and Bennett’ s Principles and Practice of Infectious Diseases5th edn. Churchill Livingstone, United States of America 2000; 2100–7
   Google Scholar
• York MK, Gibbs L, Perdreau-Remington F, Brooks GF. Characterization of antimicrobial resistance in Streptococcus pyogenes from the San Francisco Bay area of Northern California. J Clin Microbiol 1999; 37: 1727–31
   PubMed Web of Science ®Google Scholar
• Seppälä H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 30: 292–7
   Google Scholar
• Dicuonzo G, Fiscarelli E, Gherardi G, Lorino G, Battistoni F, Landii S, et al. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob Agents Chemother 2002; 46: 3987–90
   PubMed Web of Science ®Google Scholar
• Trallero-Perez E, Fernandez-Mazarrasa C, Garcia-Rey C, Bouza E, Aguilar L, Garcia-De-Lomas X, et al. Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998–1999) multicentre surveillance study in Spain. Antimicrob Agents Chemother 2001; 45: 3334–40
   PubMed Web of Science ®Google Scholar
• Martin JM, Gren M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 2002; 346: 1200–6
   PubMed Web of Science ®Google Scholar
• Yan J, Wu HM, Huang A, Fu HM, Lee CT, Wu JJ. Prevalence of polyclonal mefA-containing erythromycin resistant group A streptococci in southern Taiwan. J Clin Microbiol 2000; 38: 2475–9
   PubMed Web of Science ®Google Scholar
• Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–6
   PubMed Web of Science ®Google Scholar
• Granizo JJ, Aguilar L, Casal J, Dal-Re R, Baquero F. Streptococcus pyogenes resistance to macrolide consumption in Spain (1986–1997). J Antimicrob Chemothe 2000; 46: 959–64
   PubMed Web of Science ®Google Scholar
• Čižman M, Pokorn M, Seme K, Orazem A, Paragi M. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J Antimicrob Chemother 2001; 47: 475–7
   PubMed Web of Science ®Google Scholar
• Fischetti VA, Novick RP, Ferretti JJ. Resistance to the macrolide-lincosamide-streptogramin antibiotics. Gram Positive Pathogens. American Society for Microbiology, Washington, DC 2000; 694–710
   Google Scholar
• Vester B, Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 2001; 45: 1–12
   PubMed Web of Science ®Google Scholar
• Leclerq R, Courvalin P. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob Agents Chemother 1991; 35: 1273–6
   PubMed Web of Science ®Google Scholar
• Seppälä H, Nissinen A, Yu Q, Huovinen P. Three different phenotypes of erythromycin-resistance Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993; 32: 885–91
   PubMed Web of Science ®Google Scholar
• Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implication. Clin Infect Dis 2002; 34: 482–92
   PubMed Web of Science ®Google Scholar
• Leclercq R, Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991; 35: 1267–72
   PubMed Web of Science ®Google Scholar
• Weisblum B. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob Agents Chemother 1995; 39: 797–805
   PubMed Web of Science ®Google Scholar
• Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40: 1817–24
   PubMed Web of Science ®Google Scholar
• Weisblum B. Erythromycin resistance by ribosomal modification. Antimicrob Agents Chemother 1995; 39: 577–85
   PubMed Web of Science ®Google Scholar
• Seppälä H, Skurnik M, Soini H, Roberts MC, Huovinen P. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 1998; 42: 257–62
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Approved Standard M100-S11. NCCLS, PennsylvaniaUSA, 2001.
   Google Scholar
• Bingen E, Fitoussi F, Doit C, Cohen R, Tana A, George R, et al. Resistance to macrolides in Streptococcus pyogenes in France in paediatric patients. Antimicrob Agents Chemother 2000; 44: 1453–7
   PubMed Web of Science ®Google Scholar
• Klugman KP, Capper T, Widdowson CA, Koornhof HJ, Moser W. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae characterization of South African isolates. J Antimicrob Chemother 1998; 42: 729–34
   PubMed Web of Science ®Google Scholar
• Petinaki E, Kontos F, Pratti A, Skulakis C, Maniatis AN. Clinical isolates of macrolide-resistance Streptococcus pyogenes in central Greece. Int J Antimicrob Agents 2003; 47: 67–70
   Google Scholar
• Giovanetti E, Montanari MP, Mingoia M, Varaldo PE. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother 1999; 43: 1935–40
   PubMed Web of Science ®Google Scholar
• Reinert RR, Lütticken R, Bryskier A, Al-Lahham A. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the paediatric population in Germany during 2000–2001. Antimicrob Agents Chemother 2003; 47: 489–93
   PubMed Web of Science ®Google Scholar
• Marjdan M, Hoeck M, Hahn H, Wagner J. Antimicrobial resistance in Streptococcus pyogenes in Berlin. J Antimicrob Chemother 2000; 46: 621–3
   PubMed Web of Science ®Google Scholar
• Hasenbein ME, Warner J, Lambert KG, Cole SE, Onderdonk AB, McAdam AJ. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area. J Clin Microbiol 2004; 42: 1559–63
   PubMed Web of Science ®Google Scholar
• Cornaglia G, Ligozzi M, Valentini M, Orefici G, Fontana R. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993–1995. Emerg Infect Dis 1996; 2: 339–42
   PubMed Web of Science ®Google Scholar
• Cornaglia G, Ligozzi M, Mazzariol A, Masala L, Cascio GL, Orefici G, et al. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin Infect Dis 1998; 27(Suppl. 1)87–92
   Google Scholar
• Portillo A, Lantero M, Gastanares MJ, Ruiz-Larrea F, Torres C. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. Int J Antimicrob Agents 1999; 13: 137–40
   PubMed Web of Science ®Google Scholar
• Acikgoz ZC, Gocer S, Tuncer S. Macrolide resistance determinants of group A streptococci in Ankara, Turkey. J Antimicrob Chemother 2003; 52: 110–2
   PubMed Web of Science ®Google Scholar
• Detcheva A, Facklam RR, Beall B. Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001. J Clin Microbiol 2002; 45: 3831–4
   Google Scholar
• Jasir A, Tana A, Mirsalehian A, Mirsglehian A, Efstratiou A, Schalen C. High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study. J Clin Microbiol 2000; 38: 2103–7
   PubMed Web of Science ®Google Scholar
• Bingen E, Leclercq R, Fitoussi F, Brahimi N, Malbruny B, Deforche D, et al. Emergence of group A streptococcus strains with different mechanism of macrolide resistance. Antimicrob Agents Chemother 2002; 46: 1199–1203
   PubMed Web of Science ®Google Scholar
• Kataja J, Huovinen P, Muotiala A, Vuopio-Varkila J, Efstration A, Halas G, et al. Clonal spread of group A streptococcus with the new type of erythromycin resistance. J Infect Dis 1998; 177: 786–9
   PubMed Web of Science ®Google Scholar
• Kataja, J, Huovinen, P, The Macrolide Resistance Study Group, Seppälä, H. Erythromycin resistance genes in group A streptococci of different georaphical origins. J Antimicrob Chemother 2000;46:789–92.
   PubMed Web of Science ®Google Scholar
• Baquero, F, Garcia-Rodriguez, A, Garcia De Lomas, J, Aguilar, L, the Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial resistance of 914 beta-haemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-y (1996–1997) multicentre surveillence study. Antimicrob Agents Chemother 1999;43:178–80.
   PubMed Web of Science ®Google Scholar
• Morosini MI, Canton R, Loza E, Campo R, Almaraz F, Baquero F. Streptococcus pyogenes isolates with characterized macrolide resistance mechanism in Spain: in vitro activities of telithromycin and cethromycin. J Antimicrob Chemother 2003; 52: 50–5
   PubMed Web of Science ®Google Scholar